| Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ... International immunopharmacology 88, 106869, 2020 | 63 | 2020 |
| Classification of asthma based on nonlinear analysis of breathing pattern MR Raoufy, T Ghafari, R Darooei, M Nazari, SA Mahdaviani, ... PLoS One 11 (1), e0147976, 2016 | 57 | 2016 |
| Squill Oxymel, a traditional formulation from Drimia Maritima (L.) Stearn, as an add-on treatment in patients with moderate to severe persistent asthma: A pilot, triple-blind … F Nejatbakhsh, H Karegar-Borzi, G Amin, A Eslaminejad, M Hosseini, ... Journal of ethnopharmacology 196, 186-192, 2017 | 41 | 2017 |
| Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease H Sharifi, MR Masjedi, H Emami, M Ghanei, A Eslaminejad, G Radmand, ... Lung India 32 (6), 572-577, 2015 | 37 | 2015 |
| Role of Vitamin D Replacement on Health Related Quality of Life in Hospitalized Patients with" Acute Exacerbation of Chronic Obstructive Pulmonary Disease" MH Pourrashid, F Dastan, J Salamzadeh, A Eslaminejad, M Edalatifard Iranian journal of pharmaceutical research: IJPR 17 (2), 801, 2018 | 26 | 2018 |
| Discriminating tuberculous pleural effusion from malignant pleural effusion based on routine pleural fluid biomarkers, using mathematical methods R Darooei, G Sanadgol, A Gh-Nataj, M Almasnia, A Darivishi, ... Tanaffos 16 (2), 157, 2017 | 23 | 2017 |
| Relationship between sleep quality and mental health according to demographics of 850 patients with chronic obstructive pulmonary disease A Eslaminejad, M Safa, F Ghassem Boroujerdi, F Hajizadeh, ... Journal of health psychology 22 (12), 1603-1613, 2017 | 21 | 2017 |
| Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients P Baghaei, F Dastan, M Marjani, A Moniri, Z Abtahian, S Ghadimi, ... International Immunopharmacology 92, 107329, 2021 | 20 | 2021 |
| Effects of motivational interviewing on treatment adherence among patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial H Naderloo, Z Vafadar, A Eslaminejad, A Ebadi Tanaffos 17 (4), 241, 2018 | 19 | 2018 |
| NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals M Marjani, P Tabarsi, A Moniri, SM Hashemian, SA Nadji, Z Abtahian, ... Tanaffos 19 (2), 91, 2020 | 18 | 2020 |
| Protective effect of heart rate variability biofeedback on stress-induced lung function impairment in asthma N Taghizadeh, A Eslaminejad, MR Raoufy Respiratory physiology & neurobiology 262, 49-56, 2019 | 18 | 2019 |
| Interim report from burden of obstructive lung disease (BOLD Study) in Tehran: prevalence and risk factors of chronic obstructive pulmonary disease H Sharifi, MR Masjedi, H Emami, M Ghanei, A Eslaminejad, G Radmand, ... Tanaffos 13 (3), 6, 2014 | 17 | 2014 |
| Prevalence of tobacco use and associated factors in Tehran: Burden of Obstructive Lung Disease study H Sharifi, M Sadr, H Emami, M Ghanei, A Eslaminejad, G Radmand, ... Lung India 34 (3), 225-231, 2017 | 16 | 2017 |
| Asthma control on the basis of perceived stress, locus of control, and self-efficacy in patients with adult asthma H Heydari, B Dolatshahi, A Mahdaviani, A Eslaminejad Practice in Clinical Psychology 3 (2), 137-143, 2015 | 16 | 2015 |
| Effects of high-dose vitamin D replacement on the serum levels of systemic inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease F Dastan, J Salamzadeh, MH Pourrashid, M Edalatifard, A Eslaminejad COPD: Journal of Chronic Obstructive Pulmonary Disease 16 (3-4), 278-283, 2019 | 13 | 2019 |
| The effect of cup versus alligator forceps on the results of transbronchial lung biopsy H Jabbardarjani, A Eslaminejad, Z Mohammadtaheri, A Kiani, A Arab, ... Journal of Bronchology & Interventional Pulmonology 17 (2), 117-121, 2010 | 12 | 2010 |
| Photobiomodulation improves serum cytokine response in mild to moderate COVID-19: The first randomized, double-blind, placebo controlled, pilot study SM Marashian, M Hashemian, M Pourabdollah, M Nasseri, ... Frontiers in immunology 13, 929837, 2022 | 11 | 2022 |
| Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients A Kiani, A Eslaminejad, M Shafeipour, F Razavi, SR Seyyedi, ... Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 36 (3), 185, 2019 | 11 | 2019 |
| Speleotherapy as an effective treatment of chronic obstructive pulmonary disease A Eslaminejad, K Taghavi, M Zohal, M Kialashaki, A Fakharian J Respir Med Lung Dis. 2017; 2 (5) 1029, 2017 | 11 | 2017 |
| COVID-19-Related severe heterogeneous acute respiratory distress syndrome: A therapeutic challenge H Jamaati, L Fadaizadeh, B Khoundabi, SMR Hashemian, F Monjazabi, ... Biomedical and Biotechnology Research Journal (BBRJ) 4 (Suppl 1), S75-S82, 2020 | 9 | 2020 |
